Stockscreener 앱 받기
22.57
0.18%
-0.04
시간 외 거래:
22.55
-0.02
-0.09%
Vera Therapeutics Inc 주식(VERA)의 최신 뉴스
Strategies to average down on Vera Therapeutics Inc.2025 Market Outlook & Proven Capital Preservation Tips - Newser
Long term hold vs stop loss in Vera Therapeutics Inc.2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - Newser
What data driven models say about Vera Therapeutics Inc.’s futureJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Vera Therapeutics Inc. stock prediction for this weekTrade Risk Report & AI Enhanced Trade Execution Alerts - Newser
Intraday pattern recognizer results for Vera Therapeutics Inc.July 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Reversal indicators forming on Vera Therapeutics Inc. stockJuly 2025 Levels & Proven Capital Preservation Tips - Newser
Chart based analysis of Vera Therapeutics Inc. trendsJuly 2025 Selloffs & Safe Entry Point Identification - Newser
Can momentum traders help lift Vera Therapeutics Inc.July 2025 Big Picture & Trade Opportunity Analysis - Newser
What institutional flow reveals about Vera Therapeutics Inc.Rate Hike & Precise Swing Trade Entry Alerts - Newser
Using flow based indicators on Vera Therapeutics Inc.Weekly Stock Recap & Growth Focused Entry Point Reports - Newser
When is the best time to exit Vera Therapeutics Inc.Earnings Growth Summary & Weekly Hot Stock Watchlists - Newser
Can Vera Therapeutics’ (VERA) Widening Losses Challenge Its Path to Sustainable Growth? - Yahoo Finance
Pattern recognition hints at Vera Therapeutics Inc. upsideJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
How sentiment analysis helps forecast Vera Therapeutics Inc.July 2025 Action & Technical Pattern Based Buy Signals - Newser
Is This a Bottoming Phase for Vera Therapeutics Inc.July 2025 Outlook & AI Driven Stock Movement Reports - metrotimes.co.kr
Measuring Vera Therapeutics Inc.’s beta against major indices2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Can Vera Therapeutics Inc. stock recover from recent declineMarket Sentiment Review & Daily Momentum Trading Reports - Newser
Why Vera Therapeutics Inc. stock attracts strong analyst attentionMarket Sentiment Review & Growth Focused Stock Pick Reports - Newser
Published on: 2025-08-17 09:44:14 - metal.it
Will a bounce in Vera Therapeutics Inc. offer an exitQuarterly Trade Review & Daily Risk Controlled Trade Plans - Newser
Will Vera Therapeutics Inc. Stock Benefit from AI and Green Energy Trends2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
What’s next for Vera Therapeutics Inc. stock price2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Should I average down on Vera Therapeutics Inc. stockMarket Sentiment Report & Stock Market Timing Techniques - newsyoung.net
Vera Therapeutics Inc. Stock Performance After Earnings: Historical InsightsGold Moves & Free Safe Entry Trade Signal Reports - Newser
Vera Therapeutics shares fall 2.84% premarket after announcing inducement grants to new employees. - AInvest
Is Vera Therapeutics Inc. stock a hidden gemSmart Portfolio Allocation - thegnnews.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 - MarketScreener
10,496 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Bought by XTX Topco Ltd - Defense World
Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $53.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
What makes Vera Therapeutics Inc. stock price move sharplyFree Portfolio Health Check - thegnnews.com
How to recover losses in Vera Therapeutics Inc. stockFree Investment Plan With Growth Optimization - Newser
JPMorgan Chase & Co. Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $53.00 - Defense World
Custom watchlist performance reports with Vera Therapeutics Inc.Portfolio Safety Metrics and Return Analysis - Newser
Vera Therapeutics: Equity Incentives and BLA Timelines Signal Confidence in Value Creation - AInvest
HC Wainwright Analysts Lower Earnings Estimates for VERA - Defense World
Lifesci Capital Has Negative Estimate for VERA Q3 Earnings - Defense World
Cantor Fitzgerald Issues Negative Forecast for VERA Earnings - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $53 - 富途牛牛
Vera Therapeutics Inc. stock daily chart insightsTrade Ideas Based on Fundamental Metrics - Newser
Vera Therapeutics Awards Major Stock Package: 99,000 Options, 48,200 RSUs to Expand Team - Stock Titan
Wedbush Research Analysts Reduce Earnings Estimates for VERA - Defense World
Vera Therapeutics (VERA) to Release Quarterly Earnings on Thursday - Defense World
Can volume confirm reversal in Vera Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Vera Therapeutics Advances Clinical Trials and Financials Amid Progress Toward Commercial Launch - AInvest
Vera Therapeutics Q2 Net Loss Doubles, Revenue at $76.5 Million - AInvest
Vera (VERA) Q2 Net Loss Widens 127% - The Motley Fool
Vera Therapeutics Reports Progress in Clinical Trials - TipRanks
A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $60 to $85 - 富途牛牛
Bkv Corporation shares rise 1.82% after-hours following Vera Therapeutics' positive trial results and upcoming BLA submission. - AInvest
Vera Therapeutics Signs New Sales Agreement with TD Securities - TipRanks
Vera Therapeutics files for offering of up to $200 million Class A Common Stockfiling - MarketScreener
Form 424B5 Vera Therapeutics, Inc. - StreetInsider
Vera Therapeutics sees cash funding operations through launch of atacicept - TipRanks
Vera Therapeutics reports Q2 EPS ($1.20), consensus (62c) - TipRanks
Vera Therapeutics announces anticipated upcoming milestones - TipRanks
0.94%
1.72%
자본화:
|
볼륨(24시간):